ALTHEIA SCIENCE TOWARDS CURATIVE MEDICINE Trademark

Genetic testing for medical purposes; medical and health services relating to DNA, genetics and genetic testing; therapy services, namely, speech therapy services, medical, physical rehabilitation and physical therapy services, cognitive therapy services; Medical diabetes screening services; medical services in the field of diabetes; providing information via the Internet in the field of diabetes; medical laboratory services for the analysis of blood samples taken from patients, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; stem cell storage, namely, tissue bank services; medical services relating to the removal, treatment and processing of stem cells; therapy for diabetes, namely, medical, physical rehabilitation and physical therapy services; therapy for multiple sclerosis, namely, medical, physical rehabilitation and physical therapy services; lymphocyte gene therapy, for therapeutic purposes; haemopoietic stem cell gene therapy, for therapeutic purposes; all the above-mentioned services in the field of autoimmune diseases, rare disease and cancers

Genetic research; genetic engineering services; Genetic testing for scientific research purposes, namely, genetic fingerprinting; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; advisory services relating to gene therapy research; research in the field of gene therapy; stem cell research; all the above-mentioned services in the field of autoimmune diseases, rare disease and cancers

Reagents for use in medical genetic testing; food for diabetics, namely, dietetic foods adapted for medical use; anti-diabetic preparations; anti-diabetic pharmaceuticals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the prevention of diabetes; chemical preparations for pharmaceutical or medical purposes, namely, for the diagnosis of diabetes; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for regulating the immune system; pharmaceutical drugs in the nature of pharmaceutical preparations for the treatment of autoimmune diseases, rare disease and cancers; pharmaceutical preparations for use in hematology, namely, for the treatment of autoimmune diseases, rare disease and cancers; stem cells for medical or veterinary use; stem cells for medical purposes; surgical implants comprising living tissue grown from stem cells; drugs in the nature of pharmaceutical preparations for treating diabetes; drugs in the nature of pharmaceutical preparations for treating multiple sclerosis